Benzazepine dicarboxamide compounds

US9822065B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9822065-B1
Application numberUS-201715432859-A
CountryUS
Kind codeB1
Filing dateFeb 14, 2017
Priority dateMar 6, 2015
Publication dateNov 21, 2017
Grant dateNov 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates to novel benzazepine dicarboxamide compounds of the formula wherein R 1 to R 4 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are TLR agonists and may therefore be useful as medicaments for the treatment of diseases such as cancer, autoimmune diseases, inflammation, sepsis, allergy, asthma, graft rejection, graft-versus-host disease, immunodeficiencies, and infectious diseases.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the preparation of 2-amino-8-methoxycarbonyl-3H-1-benzazepine-4-carboxylic acid (I) comprising the step of deprotection of 4-tert-butyl 8-methyl 2-amino-3H-benzo[b]azepine-4,8-dicarboxylate (II) under acidic conditions. 2. The process according to claim 1 said process further comprising the step of reductive cyclization of compound (III) by treating compound (III) with iron and acetic acid. 3. The process according to claim 2 said process further comprising condensation of tert-butyl 3-cyano-2-(triphenylphosphoranylidene)propanoate with methyl 4-formyl-3-nitrobenzoate under basic conditions to afford methyl 4-(3-(tert-butoxy)-2-(cyanomethyl)-3-oxoprop-1-en-1-yl)-3-nitrobenzoate 4. A process for the preparation compound according to formula (VI) comprising condensation of VIII with VII basic conditions to afford methyl 4-(3-(tert-butoxy)-2-(cyanomethyl)-3-oxoprop-1-en-1-yl)-3-nitrobenzoate wherein R a and R b are C 1-6 alkyl or benzyl. 5. A compound which compound is 2-amino-8-methoxycarbonyl-3H-1-benzazepine-4-carboxylic acid, 4-tert-butyl 8-methyl 2-amino-3H-benzo[b]azepine-4,8-dicarboxylate or tert-butyl 3-cyano-2-(triphenylphosphoranylidene)propanoate.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Immunomodulators · CPC title

  • specific for metastasis · CPC title

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • Immunosuppressants, e.g. drugs for graft rejection · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9822065B1 cover?
This invention relates to novel benzazepine dicarboxamide compounds of the formula wherein R 1 to R 4 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are TLR agonists and may therefore be useful…
Who is the assignee on this patent?
Hoffmann La Roche
What technology area does this patent fall under?
Primary CPC classification A61K31/55. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).